This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom
The drug IMNOVID contains one active pharmaceutical ingredient (API):
|
1
Pomalidomide
UNII D2UX06XLB5 - POMALIDOMIDE
|
|
Pomalidomide has direct anti-myeloma tumoricidal activity, immunomodulatory activities and inhibits stromal cell support for multiple myeloma tumour cell growth. Pomalidomide in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| IMNOVID Hard capsule | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L04AX06 | L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AX Other immunosuppressants | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1622203, 1622214, 1622225, 1622236, 1796317, 1796328, 1796340, 1796351 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 113850003, 113850004 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 118823, 394022, 433311, 478395, 485147, 546345, 579260, 590263 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 61361022, 62433250, 63957170, 69941194 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 232852, 232855, 232858, 232861, 368040, 392351, 392353 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 88298, 88332, 88377, 88418 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 7405, 7406, 7407, 7408 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 042927018, 042927020, 042927032, 042927044, 042927057, 042927069, 042927071, 042927083 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1071157, 1071158, 1071159, 1071160, 1088041, 1088042, 1088043, 1088044 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 107514, 107522, 107530, 107549 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100310832, 100310849, 100310855, 100310861 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W68140001, W68141001, W68142001, W68143001 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699538154860, 8699538154877, 8699538154884, 8699538154891 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
